Intrinsic Value of S&P & Nasdaq Contact Us

Ascendis Pharma A/S ASND NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • DK • USD

SharesGrow Score
51/100
4/7 Pass
SharesGrow Intrinsic Value
$328.76
+31.6%
Analyst Price Target
$287.17
+14.9%

Over the last 12 months, insiders have made 15 transactions in ASND stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

ASND Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-23 Bienaime Jean Jacques Director Unknown 9,160 $172.35 $1.58M
2026-03-18 Wu Jay Donovan EVP & President Us Market Unknown 9,553 - -
2026-03-18 Shu Aimee EVP & Chief Medical Officer Unknown 9,552 - -
2026-03-18 Bodenhoff Mads SVP & Pao Unknown 2,768 - -
2026-03-18 Pedersen Anni Lotte Kirstine Sonderbjerg EVP & Chief Admin Officer Unknown 9,552 - -
2026-03-18 Sprogoe Kennett See Remarks Unknown 9,552 - -
2026-03-18 Holtug Lars Director Unknown 1,930 - -
2026-03-18 Jensen Michael Wolff EVP, Chief Legal Officer Unknown 9,552 - -
2026-03-18 Jensen Flemming Steen See Remarks Unknown 9,552 - -
2026-03-18 Smith Scott Thomas EVP & Chief Financial Officer Unknown 9,552 - -
2026-03-18 Imani Siham Director Unknown 1,930 - -
2026-03-18 Fairey William Director Unknown 1,930 - -
2026-03-18 Morrison Lisa Director Unknown 1,930 - -
2026-03-18 Cha Albert Director Unknown 1,930 - -
2026-03-18 Mikkelsen Jan Moller Director Unknown 28,945 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message